Work

197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with advanced cancer

Year: 2004

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(04)80205-2

Authors: J. de Bono, G. Attard, R. Plummer, S. Pacey, C. Bale, L. Vidal, A. Greystoke, N. Fox, A. Corey, H. Calvert

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2028241288

Cites:

Cited by: 9

Related to: 10